SNOA Sonoma Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1367083 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 45 since 2022-01-14, latest 2026-07-09 20:47
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 6
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-21 | 2024-06-20 | SNOA | Trombly Amy Moss | CEO | A - Grant | — | +53.6K | 153.6K | +54% | — | |
| 2024-06-21 | 2024-06-20 | SNOA | Thornton Bruce | EVP | A - Grant | — | +53.6K | 154.4K | +53% | — | |
| 2024-06-21 | 2024-06-20 | SNOA | Dal Poggetto John | Ctrl | A - Grant | — | +15.0K | 15.0K | New | — | |
| 2024-06-21 | 2024-06-20 | SNOA | DVONCH JEROME J | CFO | A - Grant | — | +53.6K | 84.6K | +173% | — | |
| 2023-07-03 | 2023-06-30 | SNOA | Thornton Bruce | EVP | A - Grant | — | +100.0K | 216.8K | +86% | — | |
| 2023-07-03 | 2023-06-30 | SNOA | Trombly Amy Moss | CEO | A - Grant | — | +100.0K | 213.6K | +88% | — |
Purchase Sale Sale after option exercise All abbreviations